What is Clorox Company (The) stock?

Clorox Company (The) Business Introduction

The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products. While best known for its namesake bleach, the company owns a diverse portfolio of trusted brands that are household staples globally. Headquartered in Oakland, California, Clorox focuses on "Health and Wellness," "Household," and "Lifestyle" segments, aiming to help people be well and thrive every day.

Detailed Business Segments

As of the latest fiscal reports (Fiscal Year 2024 and Q1 2025), Clorox organizes its operations into four primary reportable segments:

1. Health and Wellness: This segment includes cleaning, professional products, and vitamins, minerals, and supplements.
- Cleaning: Includes laundry, home care, and disinfecting products (Clorox, Pine-Sol).
- Professional Products: Solutions for healthcare, education, and commercial facilities.
- Vitamins, Minerals & Supplements (VMS): Brands like RenewLife, Natural Vitality, and NeoCell.

2. Household: This segment consists of bags and wraps, grilling, and cat litter products.
- Bags & Wraps: Glad-branded products (trash bags, food storage).
- Grilling: Kingsford and Match Light charcoal.
- Cat Litter: Fresh Step and Scoop Away.

3. Lifestyle: This segment includes food products, water filtration, and personal care.
- Food: Hidden Valley dressings, dips, and condiments.
- Water Filtration: Brita water filtration systems and filters.
- Personal Care: Burt’s Bees natural personal care products.

4. International: This segment includes sales of products outside of the United States, covering similar categories but tailored to local markets across Asia, Latin America, and Europe.

Business Model Characteristics

Portfolio Diversity: Clorox operates in distinct categories, reducing reliance on any single product line.
Premium Positioning: Many of Clorox’s brands hold the #1 or #2 market share position in their respective categories.
Brand Equity: The company invests heavily in marketing to maintain consumer trust and perceived value, allowing for premium pricing compared to generic store brands.
Asset-Light Strategy: While it manufactures many products, it leverages strategic partnerships (e.g., the Glad joint venture with P&G) to optimize supply chains and market reach.

Core Competitive Moat

Incredible Brand Loyalty: Names like Clorox, Pine-Sol, and Burt’s Bees have decades of consumer trust, which acts as a barrier to new entrants.
Market Leadership: Over 80% of the company's portfolio comes from brands with #1 or #2 market share positions.
Scale and Distribution: Clorox maintains deep relationships with major retailers like Walmart (which accounted for approximately 24% of net sales in FY2024), Target, and Amazon, ensuring prime shelf space and digital visibility.

Latest Strategic Layout: IGNITE Strategy

Clorox is currently executing its IGNITE Strategy, which focuses on:
- Fueling Growth: Accelerating innovation and brand investment.
- Digitizing the Enterprise: A $500 million multi-year investment in digital transformation, including an ERP upgrade and data-driven marketing.
- Sustainability: Integrating ESG (Environmental, Social, and Governance) goals into the core business, such as reducing plastic waste and achieving net-zero emissions by 2050.
- Recovery Post-Cyberattack: Following a significant 2023 cyberattack, the company has prioritized rebuilding its supply chain and reclaiming market share lost during the disruption.

Clorox Company (The) History

The evolution of Clorox is a journey from a single-product industrial startup to a diversified consumer goods giant.

Development Phases

Phase 1: Origins and Early Struggles (1913–1928)
Founded in 1913 as the Electro-Alkaline Company by five entrepreneurs, the company initially produced industrial-strength bleach. It nearly failed until Annie Murray, the wife of an investor, suggested a less concentrated version for home use. This pivot saved the company and established the "Clorox" brand.

Phase 2: The P&G Era and Legal Independence (1928–1969)
Clorox went public in 1928. In 1957, it was acquired by Procter & Gamble (P&G). However, the Federal Trade Commission (FTC) challenged the merger on antitrust grounds. After a decade of litigation, the Supreme Court ordered P&G to divest Clorox, and it became an independent company again in 1969.

Phase 3: Diversification and Expansion (1970–2010)
Now independent, Clorox embarked on a massive acquisition spree to reduce its dependence on bleach. Key acquisitions included:
- 1970s-80s: Kingsford Charcoal, Hidden Valley Ranch, and Glad (through a JV).
- 1990s: Brita and Pine-Sol.
- 2007: Burt’s Bees (for $925 million), marking a major entry into the "natural" personal care space.

Phase 4: Modern Era and Resilience (2011–Present)
The company shifted focus toward high-margin, health-conscious, and sustainable products. In 2020, the COVID-19 pandemic caused a historic surge in demand for disinfecting products. In 2023, the company faced a major operational hurdle due to a sophisticated cyberattack but has since shown a robust recovery in its 2024 and 2025 financial results.

Reasons for Success and Challenges

Success Factors: Effective acquisition integration, consistent dividend growth (a S&P 500 Dividend Aristocrat), and the ability to adapt to health-conscious consumer trends (e.g., Burt's Bees and Brita).
Challenges: High sensitivity to commodity costs (resin, wood, agricultural products) and the 2023 cyberattack, which caused temporary product shortages and market share erosion to private labels.

Industry Introduction

Clorox operates primarily within the Consumer Packaged Goods (CPG) industry, specifically the household and personal care sub-sectors.

Industry Trends and Catalysts

- Hyper-Focus on Wellness: Post-pandemic consumers remain highly conscious of surface disinfection and personal health.
- Sustainability: Increasing regulatory and consumer pressure to reduce single-use plastics and use "green" ingredients.
- E-commerce Growth: A shift from traditional retail to omnichannel and direct-to-consumer (DTC) models.
- Input Cost Volatility: Fluctuations in logistics and raw material prices (like resin for bags) significantly impact margins.

Competitive Landscape

The CPG industry is fiercely competitive, characterized by high-volume players and rising private-label (store brand) competition.

Clorox’s Industry Status

Clorox is considered a "Category Captain" in several niches. In the United States, Clorox holds a dominant position in the bleach and charcoal markets. According to recent 2024 data, Clorox maintains a consolidated gross margin of approximately 43-45%, reflecting its ability to command premium prices despite intense competition. While smaller in revenue compared to giants like P&G, Clorox’s high concentration of #1 brands gives it significant bargaining power with retailers.

Clorox Company (The) Financial Health Score

The Clorox Company (CLX) maintains a solid financial profile characterized by high profitability and strong cash flow generation, though it carries a leveraged balance sheet typical of the consumer staples sector. As of the end of Fiscal Year 2025 (ended June 30, 2025) and into early 2026, the company has shown a remarkable recovery in margins following previous operational disruptions.

CLX Development Potential

IGNITE+ Strategy and Digital Transformation

Clorox is currently executing its IGNITE+ strategic plan, which targets long-term organic sales growth of 3% to 5%. A major catalyst is the completion of a $500 million digital transformation program. In early 2025, the company deployed AI-driven demand forecasting, which has already reduced out-of-stock incidents by 15% across top retail partners, significantly enhancing supply chain efficiency.

Portfolio Optimization and "CloroxPro" Growth

The company has aggressively reshaped its portfolio by divesting non-core assets, such as the Vitamins, Minerals and Supplements (VMS) business in late 2024, to focus on high-margin core brands. The CloroxPro segment remains a high-potential catalyst, aiming for double-digit annual growth by expanding clinical-grade disinfection services into the hospitality and education sectors across North America and Western Europe.

Innovation Pipeline and Market Share Recovery

After the 2023 cyberattack, Clorox successfully restored its market share in 2024 and 2025. Future growth is tied to a robust innovation pipeline, including Clorox EcoClean plant-based wipes and premium Glad ForceFlex MaxStrength products. These "value superiority" innovations allow the company to maintain pricing power even as consumer spending remains cautious.

Clorox Company (The) Upside and Risks

Company Upside (Pros)

1. Margin Expansion: Clorox has achieved eight consecutive quarters of gross margin expansion as of late 2024, driven by holistic margin management (HMM) and cost-saving initiatives.
2. Defensive Market Position: Over 80% of Clorox’s brands hold the #1 or #2 market share position in their categories, providing a stable revenue base during economic volatility.
3. Strong Dividend Profile: With a dividend yield frequently exceeding 4% and a long history of annual increases, the stock remains a top pick for income-oriented investors.

Company Risks (Cons)

1. Transitory ERP Headwinds: For Fiscal Year 2026, management has projected a temporary decline in net sales (estimated down 6% to 10%) as retailers draw down excess inventory built up prior to the company's system transition.
2. Private Label Competition: Increasing pressure from "private label" (store brands) poses a threat to national brands. Data indicates private labels gained 30 basis points of market share in 2024, particularly in the home care category.
3. Input Cost Volatility: While margins are currently healthy, the company remains sensitive to fluctuations in raw material costs (resins, chemicals) and logistics inflation, which could compress future earnings if price increases cannot be sustained.

How Analysts View The Clorox Company and CLX Stock?

Heading into the mid-2024 fiscal period and looking toward 2025, market sentiment regarding The Clorox Company (CLX) remains a blend of cautious optimism and strategic monitoring. Following a turbulent period marked by a significant cybersecurity breach in late 2023, analysts are now focusing on the company's volume recovery and margin expansion capabilities. Here is a detailed breakdown of how Wall Street views Clorox:

1. Core Institutional Perspectives on Company Performance

Operational Recovery Post-Cyberattack: The consensus among major firms like JPMorgan Chase and Wells Fargo is that Clorox has demonstrated remarkable resilience. After the August 2023 cyberattack disrupted production, the company successfully restored its supply chain faster than initially feared. Analysts note that as of the third quarter of fiscal year 2024, Clorox has regained the vast majority of its lost market share in key categories like bleach, water filtration, and grilling.

Focus on Margin Expansion: Analysts are particularly impressed by Clorox's IGNITE strategy. By implementing aggressive cost-savings initiatives and strategic pricing, the company reported a significant expansion in gross margins—reaching 42.2% in Q3 2024, a substantial year-over-year increase. Goldman Sachs analysts highlight that the shift toward a more digitized supply chain and personalized consumer engagement is fundamentally strengthening the company's earnings power.

Product Innovation and Brand Strength: Despite inflationary pressures on consumers, analysts believe Clorox’s "superior value" proposition keeps its brands relevant. The Health and Wellness segment remains a cornerstone, though analysts are closely watching the Household and Lifestyle segments for signs of price elasticity as consumers trade down to private labels.

2. Stock Ratings and Price Targets

As of mid-2024, the market consensus for CLX stock leans toward a "Hold" or "Sector Perform," with a growing number of analysts turning bullish as the valuation stabilizes.

Rating Distribution: Among the approximately 20 analysts covering the stock, the majority maintain a "Hold" rating, while about 25% have upgraded the stock to "Buy" following the recent earnings beats. A small minority still maintain "Sell" ratings due to valuation concerns.

Price Target Forecasts:
Average Price Target: Approximately $155 - $165 per share, representing a modest upside from current trading levels.
Optimistic Outlook: Top-tier bulls, such as DA Davidson, have set targets as high as $170 - $180, citing faster-than-expected earnings per share (EPS) growth and the potential for increased dividend hikes.
Conservative Outlook: More cautious firms, like Morgan Stanley, keep targets near $145, arguing that the stock is currently trading at a premium P/E ratio relative to its historical average and its peers in the consumer staples sector.

3. Key Risk Factors Highlighted by Analysts

While the recovery is underway, analysts urge investors to consider the following headwinds:

Consumer Spending Headwinds: There is persistent concern that if high interest rates continue to squeeze household budgets, even "must-have" cleaning products might see volume declines as shoppers switch to generic store brands.

Advertising and Promotion (A&P) Spending: To win back the shelf space lost during the cyberattack, Clorox has had to ramp up promotional spending. Analysts at Stifel point out that while this supports volume growth, it could temporarily weigh on operating margins in the short term.

Input Cost Volatility: While commodity costs have stabilized compared to the 2022-2023 peaks, fluctuations in resin, diesel, and agricultural raw materials (for the Kingsford charcoal business) remain a risk to the company’s 2025 fiscal outlook.

Summary

The prevailing view on Wall Street is that The Clorox Company has successfully moved past its recent operational crises. Analysts see CLX as a high-quality "defensive play" with a reliable dividend yield (currently around 3.2% - 3.5%). While the stock may not offer the explosive growth of tech sectors, its steady recovery in market share and disciplined cost management make it an attractive core holding for income-focused investors looking for stability in a volatile macroeconomic environment.

Clorox Company (The) Frequently Asked Questions (FAQ)

What are the key investment highlights for Clorox (CLX) and who are its main competitors?

The Clorox Company (CLX) is a leading multinational manufacturer of consumer and professional products, with approximately 80% of its sales coming from brands that hold the No. 1 or No. 2 market share positions in their categories. Key investment highlights include its strong brand equity (Clorox, Pine-Sol, Glad, Brita, Burt's Bees), a robust dividend history (part of the S&P 500 Dividend Aristocrats index), and its "IGNITE" strategy focused on digital transformation and sustainability.
Major competitors include global consumer staple giants such as Procter & Gamble (PG), Church & Dwight (CHD), Reckitt Benckiser, and Colgate-Palmolive (CL).

Is Clorox's latest financial data healthy? How are the revenue, net income, and debt levels?

Based on the fiscal 2024 second-quarter results (ending December 31, 2023), Clorox has shown a significant recovery following a major cyberattack in late 2023.
Revenue: Reported net sales increased 16% to $1.99 billion compared to the year-ago quarter, driven largely by volume recovery as the company rebuilt inventory.
Net Income: The company reported GAAP net income of $106 million ($0.85 per diluted share), a significant improvement over the previous quarter's losses.
Debt: Clorox maintains a manageable leverage profile, though its debt-to-EBITDA ratio saw temporary pressure due to the cyberattack's impact on earnings. As of early 2024, the company is focused on restoring its gross margin, which expanded 730 basis points to 43.5% in the latest quarter.

Is the current CLX stock valuation high? How do the P/E and P/B ratios compare to the industry?

As of Q1 2024, Clorox often trades at a premium compared to the broader market due to its defensive nature. Its Forward P/E ratio typically ranges between 25x and 30x, which is slightly higher than the household products industry average.
Its Price-to-Book (P/B) ratio is significantly higher than peers, often exceeding 100x, which is a result of the company's aggressive share repurchase programs over the years that have reduced stockholders' equity. Investors generally focus more on Free Cash Flow (FCF) yield and Price-to-Earnings when evaluating CLX.

How has CLX stock performed over the past three months and year compared to its peers?

Over the past year, CLX stock has experienced volatility, largely underperforming the S&P 500 due to the operational disruptions caused by the August 2023 cyberattack. However, over the past three months (leading into early 2024), the stock has seen a strong rebound, gaining over 15% as the company restored supply levels faster than analysts anticipated.
Compared to the Consumer Staples Select Sector SPDR Fund (XLP), Clorox has shown higher beta (volatility) recently but is currently trending toward a recovery phase that aligns with top-tier peers like P&G.

Are there any recent tailwinds or headwinds for the household products industry?

Tailwinds: Easing raw material costs and logistics expenses are helping expand gross margins across the sector. Additionally, consumer trade-down to "value" brands has been less severe than expected for premium brands like Clorox.
Headwinds: Persistent inflation continues to pressure consumer purchasing power. For Clorox specifically, the primary headwind has been the cyberattack recovery costs and the need to reinvest heavily in promotional spending to regain shelf space lost during the supply outage.

Have major institutional investors been buying or selling CLX stock recently?

Institutional ownership in Clorox remains high, at approximately 78% to 80%. According to recent 13F filings for the period ending December 31, 2023, major asset managers like Vanguard Group and BlackRock maintain significant positions. While some funds trimmed holdings following the cyberattack-induced earnings dip, there has been renewed "dip-buying" activity from value-oriented institutional investors as the company's margin recovery story gains momentum in 2024.